青木 大輔 あおき だいすけ 先生

来歴等

略歴

1982年 慶應義塾大学医学部 卒業
1982年 慶應義塾大学医学部 研修医（産婦人科）
1986年 慶應義塾大学 助手（医学部産婦人科学）
1988年 米国La Jolla Cancer Research Foundation（現Sanford Burnham Prebys Medical Discovery Institute） Postdoctoral fellow
1989年 医学博士 取得
1996年 慶應義塾大学 専任講師（医学部産婦人科学）
2005年 慶應義塾大学 教授（医学部産婦人科学）
2023年 慶應義塾大学 名誉教授
2023年 国際医療福祉大学大学院 教授／赤坂山王メディカルセンター 院長

論文

• Japanese Gynecologic Oncology Group: Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression: A Randomized Clinical Trial. JAMA Oncol, 5: 833-840, 2019

  Nomura H, Aoki D, Michimae H, Mizuno M, Nakai H, Arai M, Sasagawa M, Ushijima K, Sugiyama T, Saito M, Tokunaga H, Matoda M, Nakanishi T, Watanabe Y, Takahashi F, Saito T, Yaegashi N

• A Clinical Trial to Verify the Efficiency of the LC-1000 Exfoliative Cell Analyzer as a New Method of Cervical Cancer Screening. Acta Cytol, 63: 391-400, 2019

  Nakamura M, Ueda M, Iwata T, Kiguchi K, Mikami Y, Kakuma T, Aoki D

• Liquid-based cytology versus conventional cytology for detection of uterine cervical lesions: a prospective observational study. Jpn J Clin Oncol, 48: 522-528, 2018

  Nishio H, Iwata T, Nomura H, Morisada T, Takeshima N, Takano H, Sasaki H, Nakatani E,Teramukai S, Aoki D

• Population-based cohort study assessing the efficacy of cervical cytology (Pap smear) and human papillomavirus (HPV) testing as modalities for cervical cancer screening. Jpn J Clin Oncol, 48:495-498, 2018

  Morisada T, Saika K, Saito E, Kono K, Saito H, Aoki D

• Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer. Oncotarget, 8: 112258-112267, 2017

  Hirasawa A, Imoto I, Naruto T, Akahane T, Yamagami W, Nomura H, Masuda K, Susumu N, Tsuda H, Aoki D

• HMMC-1, a human monoclonal antibody to fucosylated core 1 O-glycan, suppresses growth of uterine endometrial cancer cells. Cancer Sci, 104: 62-69, 2013

  Oikawa F, Kojima-Aikawa K, Inoue F, Suzuki A, Tanaka K, Tominaga E, Aoki D

• Experience of Risk-reducing Salpingo-oophorectomy for a BRCA1 Mutation Carrier and Establishment of a System Performing a Preventive Surgery for Hereditary Breast and Ovarian Cancer Syndromein Japan: Our Challenges for the Future. Jpn J Clin Oncol, 43:515-519, 2013

  Hirasawa A, Masuda K, Akahane T, Tsuruta T, Banno K, Makita K, Susumu N, Jinno, H, Kitagawa Y, Sugano K, Kosaki K, Aoki D

• Lobular endocervical glandular hyperplasia and peritoneal pigmentation associated with Peutz-Jeghers syndrome due to a germline mutation of STK11. Ann Oncol, 23: 2990-2992, 2012

  Hirasawa A, Akahane T, Tsututa T, Kobayashi Y, Masuda K, Banno K, Fujii T, Susumu N, Itsubo T, Kameyama K, Sugano K, Aoki D

• A phase II clinical trial of topotecan in Japanese patients with relapsed ovarian carcinoma. Jpn J Clin Oncol, 41: 320-327, 2011

  Aoki D, Katsumata N, Nakanishi T, Kigawa J, Fujiwara K, Takehara K, Kamiura S, Hiura M, Hatae M, Sugiyama T, Ochiai K, Noda K

• Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma. Clin Cancer Res, 15: 1473-1480, 2009

  Aoki D, Oda Y, Hattori S, Taguchi K, Ohishi Y, Basaki Y, Oie S, Suzuki N, Kono S, Tsuneyoshi M, Ono M, Yanagawa T, Kuwano M

• Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancer. Anticancer Res, 29: 561-566, 2009

  Aoki D, Watanabe Y, Jobo T, Ushijima K, Hasegawa K, Susumu N, Suzuki N, Aoki R, Isonishi S, Sagae S, Ishizuka B, Kamura T, Udagawa Y, Hoshiai H, Ohashi Y, Ochiai K, Noda K

著書

• 【共著】Precision Medicine in Gynecology and Obstetrics, Springer, 2017

• 【共著】分子腫瘍マーカー診療ガイドライン，金原出版，2016

• 【監訳】遺伝性婦人科癌－リスク・予防・マネジメント，医学書院，2011

• 【編著者】子宮がん・卵巣がん全書：1-775，法研，東京，2005

その他

• 【受賞】慶應義塾大学医学部三四会三四会奨励賞，1989年

• 【受賞】日本臨床電子顕微鏡学会奨励賞，2002年

• 【受賞】第５回神澤医学賞，2003年